Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04788602
Other study ID # 202010048RINB
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2019
Est. completion date December 31, 2023

Study information

Verified date December 2023
Source National Taiwan University Hospital
Contact Wan-Ching Lien
Phone +886-23123456
Email wanchinglien@ntu.edu.tw
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Transthoracic echocardiography (TTE) is known to be an effective modality in assessing cardiac function as well as the structure of the heart. It was estimated that between 15% and 30% of ischemic strokes were due to a cardioembolic source, Therefore, TTE has been assumed as an important screening tool in patients with ischemic stroke, as atrial fibrillation is one of the leading risk factors. However, current guidelines have little evidence in whether performing TTE can alter clinical management and prevent a future stroke. We aim to present the association of performing TTE and clinical outcomes in stroke patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - patients with acute stroke and receiving echocardiography Exclusion Criteria: - patients with acute stroke and not receiving echocardiography

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan Department of Emergency Medicine, National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary recurrent stroke the correlation between the echocardiography and recurrence of stroke one year